<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D187BAD9-A3C7-4EEF-BAA9-D1554C22483F"><gtr:id>D187BAD9-A3C7-4EEF-BAA9-D1554C22483F</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Robson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700562"><gtr:id>2E7E6363-DC44-4BD1-A109-CD2AA76EF2EB</gtr:id><gtr:title>Origin and Function of the Stroma in Cholangiocarcinoma</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700562</gtr:grantReference><gtr:abstractText>The bile duct is a tube that connects the liver to the intestines. It delivers the waste products of the liver to the gut. Cancer of the bile duct (cholangiocarcinoma) is rarely curable, has a poor survival and is increasingly common worldwide. We aim to study the role that the body?s own immune cells (such as macrophages) play in cholangiocarcinoma. 
There is evidence that macrophages can increase tumour cell growth in certain situations. Cholangiocarcinoma tumours are surrounded by these cells and we are trying to discover whether these may be important in the development of this cancer.
We aim to investigate the relationship between the cancer cells and immune cells. This may eventually result in the development of novel treatments for this cancer.</gtr:abstractText><gtr:technicalSummary>Background
Cholangiocarcinoma (CC) is the second commonest primary liver malignancy. The worldwide incidence of CC is increasing rapidly and the prognosis is dismal. Chemotherapy is ineffective; very few patients are candidates for surgery. Even for resectable lesions the 5-year survival rates are at best 30-40% for hilar lesions and 22-36% for intrahepatic CC.

Relevance 
Inflammation, from a variety of causes, is a strong risk factor for CC. Intrahepatic CC is characterised by a pronounced desmoplastic response (stroma) consisting primarily of macrophages, myofibroblasts and extra-cellular matrix. The stromal components of cancers have been shown to promote invasiveness, tumour survival and resistance to therapy. In a number of tumours a proportion of the cancer-associated stroma is derived from Bone Marrow (BM). 

A variety of signalling molecules, including Notch, have been implicated in the progression of CC. Manipulating the stromal component of CC may provide novel therapeutic options.

Aims and Objectives
To define the origin and functional role of the stroma in CC by:

1) Defining the composition and origin of CC associated stroma during the formation of CC.
2) Performing functional analyses of the stromal cell-CC interaction. 

Design and Methodology
1. Perform BM transplants prior to cancer induction in a model of CC development to define the composition and origin of the cancer associated stroma. 
2. Deplete macrophages and myofibroblasts in independent validated protocols during CC development and analyse the functional relationship between the stroma and the CC.
3. Carry out in vitro culture studies of CC and stromal cells to analyse the stromal cell-CC interaction. Studies of CC cell behaviour in response to soluble factors and extra-cellular matrix components will be performed. The role of specific signalling molecules, including Notch, will be assessed.

Scientific and Medical opportunities of the study
To date the treatment options for cholangiocarcinoma are limited and chemotherapy directed at the CC cells is largely ineffective. We believe this study will define the origin, composition and functional role of the CC associated stroma- including a definition of the specific signals that mediate the growth promoting and chemo-protective effects of the stroma. This may enable the future development of specific therapies for the treatment of CC that may target either the stroma or the stroma-CC interaction.</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>247685</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Alpine Liver and Pancreatic Society annual meeting 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>25D381F4-5A04-4DAD-8A20-908CF7520918</gtr:id><gtr:impact>50 surgeons and health professionals attended an annual meeting at which I presented data. This was awarded the prize for best presentation at the meeting

I have been invited to return the following year (2011) as an invited speaker to provide an update on findings and general eduication regarding cholangiocarcinoma therapeutic options.</gtr:impact><gtr:outcomeId>encF1Pt2V1G</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Liver Cancer Multidisciplinary Network</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2DFE19B2-9C11-4DCE-869D-09D59FDB074B</gtr:id><gtr:impact>Described our research findings to an audience of clinicians, oncology nursing staff, paramedical specialists, and patients.

Clinical interest in findings, discussions regarding applicability of basic science research to clinical oncology.</gtr:impact><gtr:outcomeId>5FF1A8F9D1C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The thioacetamide induction protocol in rats is a recognised model of cholangiocarcinoma but is unpredicatable in terms of tumour penetrance. We have modified this to generate tumours uniformly and more quickly in wild type rats.</gtr:description><gtr:id>E2BAD7B7-69F5-4693-8857-92AD1EF05420</gtr:id><gtr:impact>Lead time from experimental start to conclusion is significantly shorter and more reliable.</gtr:impact><gtr:outcomeId>A4F9E851A6B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cholangiocarcinoma Rat Model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using materials already commercially available, and building on other groups work, we have established a direct co-culture system of stromal and epithelial cells and are able to identify both cell types in culture.</gtr:description><gtr:id>A5894F6A-1A3C-4EA3-9A96-0F5A1C4F73C2</gtr:id><gtr:impact>Data analysis ongoing</gtr:impact><gtr:outcomeId>A1D820FBE20</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Stromal-Epithelial Direct Co-culture</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F7ED654F-23D0-4FFC-A12D-B89FD8D861C3</gtr:id><gtr:title>Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d3c4db5444be357dea85492f795ee6a"><gtr:id>3d3c4db5444be357dea85492f795ee6a</gtr:id><gtr:otherNames>Pellicoro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>pm_16606_26_22223197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24AD584A-9CB3-411B-81FF-9332E37F08F5</gtr:id><gtr:title>Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57cc8704e3792ad9d960f7c56d10fd49"><gtr:id>57cc8704e3792ad9d960f7c56d10fd49</gtr:id><gtr:otherNames>Kallis YN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_16606_26_21106552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>309A9697-0443-4B64-8058-3DBC2E244C5D</gtr:id><gtr:title>Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbb6c2dbdbbbb0453b95e990fc58eae7"><gtr:id>bbb6c2dbdbbbb0453b95e990fc58eae7</gtr:id><gtr:otherNames>Thomas JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>pm_16606_26_21433043</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700562</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>